These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 24879157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
    Acquaviva J, Smith DL, Jimenez JP, Zhang C, Sequeira M, He S, Sang J, Bates RC, Proia DA.
    Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
    [Abstract] [Full Text] [Related]

  • 5. USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy.
    Ma ZR, Xiong QW, Cai SZ, Ding LT, Yin CH, Xia HL, Liu W, Dai S, Zhang Y, Zhu ZH, Huang ZJ, Wang Q, Yan XM.
    Int Immunopharmacol; 2023 Sep; 122():110617. PubMed ID: 37478666
    [Abstract] [Full Text] [Related]

  • 6. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma.
    Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J, Hart LS, Levi S, Hu J, Zhang G, Lazova R, Klump V, Pawelek JM, Xu X, Xu W, Schuchter LM, Davies MA, Herlyn M, Winkler J, Koumenis C, Amaravadi RK.
    J Clin Invest; 2014 Mar; 124(3):1406-17. PubMed ID: 24569374
    [Abstract] [Full Text] [Related]

  • 7. BRAF V600E-dependent role of autophagy in uveal melanoma.
    Zhao Y, Wang W, Min I, Wyrwas B, Moore M, Zarnegar R, Fahey TJ.
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):447-455. PubMed ID: 27928645
    [Abstract] [Full Text] [Related]

  • 8. Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.
    Levy JM, Thompson JC, Griesinger AM, Amani V, Donson AM, Birks DK, Morgan MJ, Mirsky DM, Handler MH, Foreman NK, Thorburn A.
    Cancer Discov; 2014 Jul; 4(7):773-80. PubMed ID: 24823863
    [Abstract] [Full Text] [Related]

  • 9. Dangerous liaisons: flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas.
    Shenolikar S.
    J Clin Invest; 2014 Mar; 124(3):973-6. PubMed ID: 24569370
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors.
    Basile KJ, Le K, Hartsough EJ, Aplin AE.
    Pigment Cell Melanoma Res; 2014 May; 27(3):479-84. PubMed ID: 24422853
    [Abstract] [Full Text] [Related]

  • 13. A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice.
    Feng JH, Nakagawa-Goto K, Lee KH, Shyur LF.
    Mol Cancer Ther; 2016 Jun; 15(6):1163-76. PubMed ID: 27048951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.
    Peh J, Fan TM, Wycislo KL, Roth HS, Hergenrother PJ.
    Mol Cancer Ther; 2016 Aug; 15(8):1859-69. PubMed ID: 27297867
    [Abstract] [Full Text] [Related]

  • 18. EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.
    Miao B, Ji Z, Tan L, Taylor M, Zhang J, Choi HG, Frederick DT, Kumar R, Wargo JA, Flaherty KT, Gray NS, Tsao H.
    Cancer Discov; 2015 Mar; 5(3):274-87. PubMed ID: 25542448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.
    Das Thakur M, Salangsang F, Landman AS, Sellers WR, Pryer NK, Levesque MP, Dummer R, McMahon M, Stuart DD.
    Nature; 2013 Feb 14; 494(7436):251-5. PubMed ID: 23302800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.